A mutation in the saposin A coding region of the prosaposin gene in an infant presenting as Krabbe disease: first report of saposin A deficiency in humans

被引:83
作者
Spiegel, R
Bach, G
Sury, V
Mengistu, G
Meidan, B
Shalev, S
Shneor, Y
Mandel, H
Zeigler, M [1 ]
机构
[1] Hadassah Univ Hosp, Dept Human Genet, IL-91120 Jerusalem, Israel
[2] HaEmek Med Ctr, Inst Human Genet, Afula, Israel
[3] HaEmek Med Ctr, Dept Pediat, Afula, Israel
[4] Rambam Med Ctr, Metab Dis Unit, Haifa, Israel
[5] Rambam Med Ctr, Dept Pediat, Haifa, Israel
关键词
Krabbe disease; sphingolipid activator proteins; prosaposin; saposin A; saposin C; galactocerebrosidase; galactosylceramide; sulphatide loading;
D O I
10.1016/j.ymgme.2004.10.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A six-month-old infant girl presenting with progressive encephalopathy and abnormal myelination in the cerebral white matter was originally diagnosed as suffering from Krabbe disease. The diagnosis was based on a deficiency of galactocerebrosidase activity found in leukocytes isolated from whole blood. When cultured skin fibroblasts did not show a similar enzyme deficiency and sulphatide (stearoyl-1-C-14) uptake indicated an abnormal storage of galactosylceramide, a deficiency of an activator was implied. A three base pair deletion was found in the saposin A coding sequence of the prosaposin gene leading to the deletion of a conserved valine at amino acid number 11 of the saposin A protein. This deletion in saposin A is proposed as the cause for the abnormal galactosylceramide metabolism in this infant. This is the first report of a saposin A mutation in humans leading to pathological consequences. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:160 / 166
页数:7
相关论文
共 28 条
[1]   DISCRIMINATION BETWEEN METACHROMATIC LEUKODYSTROPHY AND PSEUDO-DEFICIENCY OF ARYLSULFATASE-A BY RESTRICTION DIGEST OF AMPLIFIED GENE FRAGMENTS [J].
BENYOSEPH, Y ;
MITCHELL, DA .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1995, 309 (02) :88-91
[2]   PROSAPOSIN DEFICIENCY - FURTHER CHARACTERIZATION OF THE SPHINGOLIPID ACTIVATOR PROTEIN-DEFICIENT SIBS - MULTIPLE GLYCOLIPID ELEVATIONS (INCLUDING LACTOSYLCERAMIDOSIS), PARTIAL ENZYME DEFICIENCIES AND ULTRASTRUCTURE OF THE SKIN IN THIS GENERALIZED SPHINGOLIPID STORAGE DISEASE [J].
BRADOVA, V ;
SMID, F ;
ULRICHBOTT, B ;
ROGGENDORF, W ;
PATON, BC ;
HARZER, K .
HUMAN GENETICS, 1993, 92 (02) :143-152
[3]  
Burkhardt JK, 1997, EUR J CELL BIOL, V73, P10
[4]   ACTIVATOR PROTEINS AND TOPOLOGY OF LYSOSOMAL SPHINGOLIPID CATABOLISM [J].
FURST, W ;
SANDHOFF, K .
BIOCHIMICA ET BIOPHYSICA ACTA, 1992, 1126 (01) :1-16
[5]   Saposins (sap) A and C activate the degradation of galactosylceramide in living cells [J].
Harzer, K ;
Paton, BC ;
Christomanou, H ;
Chatelut, M ;
Levade, T ;
Hiraiwa, M ;
OBrien, JS .
FEBS LETTERS, 1997, 417 (03) :270-274
[6]   SPHINGOLIPID ACTIVATOR PROTEIN-DEFICIENCY IN A 16-WEEK-OLD ATYPICAL GAUCHER DISEASE PATIENT AND HIS FETAL SIBLING - BIOCHEMICAL SIGNS OF COMBINED SPHINGOLIPIDOSES [J].
HARZER, K ;
PATON, BC ;
POULOS, A ;
KUSTERMANNKUHN, B ;
ROGGENDORF, W ;
GRISAR, T ;
POPP, M .
EUROPEAN JOURNAL OF PEDIATRICS, 1989, 149 (01) :31-39
[7]   Saposins (sap) A and C activate the degradation of galactosylsphingosine [J].
Harzer, K ;
Hiraiwa, M ;
Paton, BC .
FEBS LETTERS, 2001, 508 (01) :107-110
[8]  
Henseler M, 1996, AM J HUM GENET, V58, P65
[9]  
Hiraiwa M, 1999, GLIA, V26, P353, DOI 10.1002/(SICI)1098-1136(199906)26:4<353::AID-GLIA9>3.3.CO
[10]  
2-7